降钙素基因相关肽在偏头痛治疗中的研究进展(5)
[21]Dodick DW，Goadsby PJ，Silberstein SD，et al.Safety and efficacy of ALD403，an antibody to calcitonin gene-related peptide，for the prevention of frequent episodic migraine： a randomised，double-blind，placebo-controlled，exploratory phase 2 trial[J].Lancet Neurol，2014，13(11)：1100-1107.
[22]Hong P，Wu X，Liu Y.Calcitonin gene-related peptide monoclonal antibody for preventive treatment of episodic migraine：a meta analysis[J].Clin Neurol Neurosurg，2017， 154：74-78.
[23]Sun H，Dodick DW，Silberstein S，et al.Safety and efficacy of AMG 334 for prevention of episodic migraine： a randomised，double-blind，placebo-controlled，phase 2 trial[J].Lancet Neurol，2016，15(4)：382-390.
[24]Dodick DW，Ashina M，Brandes JL，et al.Arise：a Phase 3 randomized trial of erenumab for episodic migraine[J].Cephalalgia，2018，38(6)：1026-1037.
[25]Tepper S，Ashina M，Reuter U，et al.Safety and efficacy of erenumab for preventive treatment of chronic migraine：a randomised，double-blind，placebo-controlled phase 2 trial[J].Lancet Neurol，2017，16(6)：425-434.
[26]Tso AR，Goadsby PJ.Anti-CGRP monoclonal antibodies：the next era of migraine prevention？[J].Curr Treat Options Neurol，2017，19(8)：27.
(收稿日期：2018-04-02 本文編辑：闫 佩), http://www.100md.com(王飞)
[22]Hong P，Wu X，Liu Y.Calcitonin gene-related peptide monoclonal antibody for preventive treatment of episodic migraine：a meta analysis[J].Clin Neurol Neurosurg，2017， 154：74-78.
[23]Sun H，Dodick DW，Silberstein S，et al.Safety and efficacy of AMG 334 for prevention of episodic migraine： a randomised，double-blind，placebo-controlled，phase 2 trial[J].Lancet Neurol，2016，15(4)：382-390.
[24]Dodick DW，Ashina M，Brandes JL，et al.Arise：a Phase 3 randomized trial of erenumab for episodic migraine[J].Cephalalgia，2018，38(6)：1026-1037.
[25]Tepper S，Ashina M，Reuter U，et al.Safety and efficacy of erenumab for preventive treatment of chronic migraine：a randomised，double-blind，placebo-controlled phase 2 trial[J].Lancet Neurol，2017，16(6)：425-434.
[26]Tso AR，Goadsby PJ.Anti-CGRP monoclonal antibodies：the next era of migraine prevention？[J].Curr Treat Options Neurol，2017，19(8)：27.
(收稿日期：2018-04-02 本文編辑：闫 佩), http://www.100md.com(王飞)